• Citer

Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.

par Hauser, Carl;Boffard, Kenneth;Dutton, Richard;Bernard, Gordon;Croce, Martin;Holcomb, John;Leppäniemi, Ari;Parr, Michael;Vincent, Jean Louis ;Tortella, Bartholemew;Dimsits, Jeannett;Bouillon, Bertil;CONTROL Study Group,
Référence The Journal of trauma, 69, 3, page (489-500)
Publication Publié, 2010-09

Article révisé par les pairs

• Détails
• Contenu

Titre:	Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
Auteur:	Hauser, Carl; Boffard, Kenneth; Dutton, Richard; Bernard, Gordon; Croce, Martin; Holcomb, John; Leppäniemi, Ari; Parr, Michael; Vincent, Jean Louis; Tortella, Bartholemew; Dimsits, Jeannett; Bouillon, Bertil; CONTROL Study Group,
Informations sur la publication:	The Journal of trauma, 69, 3, page (489-500)
Statut de publication:	Publié, 2010-09
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adolescent
	Adult
	Aged
	Blood Transfusion
	Double-Blind Method
	Factor VIIa -- adverse effects -- therapeutic use
	Female
	Hemorrhage -- drug therapy -- mortality -- therapy
	Hemostasis -- drug effects
	Humans
	Male
	Middle Aged
	Prospective Studies
	Recombinant Proteins -- adverse effects -- therapeutic use
	Treatment Outcome
	Wounds and Injuries -- complications -- drug therapy -- mortality
	Wounds, Nonpenetrating -- complications -- drug therapy -- mortality
	Wounds, Penetrating -- complications -- drug therapy -- mortality
	Young Adult
Note générale:	Clinical Trial, Phase III
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0022-5282
	info:doi/10.1097/TA.0b013e3181edf36e
	info:pii/00005373-201009000-00002
	info:pmid/20838118